These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 27615379)
1. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis. Thonsri U; Seubwai W; Waraasawapati S; Sawanyawisuth K; Vaeteewoottacharn K; Boonmars T; Cha'on U Histol Histopathol; 2017 May; 32(5):503-510. PubMed ID: 27615379 [TBL] [Abstract][Full Text] [Related]
2. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma. Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275 [TBL] [Abstract][Full Text] [Related]
3. CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma. Gu M Int J Clin Exp Pathol; 2015; 8(1):862-6. PubMed ID: 25755787 [TBL] [Abstract][Full Text] [Related]
4. High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma. Sun Q; Zhao C; Xia L; He Z; Lu Z; Liu C; Jia M; Wang J; Niu J Int J Clin Exp Pathol; 2014; 7(9):6157-64. PubMed ID: 25337264 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of neutrophil distribution in cholangiocarcinoma. Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010 [TBL] [Abstract][Full Text] [Related]
6. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131 [TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of microRNA-203 in cholangiocarcinoma. Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713 [TBL] [Abstract][Full Text] [Related]
15. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma. Chu X; Zhao P; Lv Y; Liu L Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719 [TBL] [Abstract][Full Text] [Related]
16. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas. Lee D; Do IG; Choi K; Sung CO; Jang KT; Choi D; Heo JS; Choi SH; Kim J; Park JY; Cha HJ; Joh JW; Choi KY; Kim DS Mod Pathol; 2012 Jan; 25(1):131-9. PubMed ID: 21874010 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer. Komatsubara T; Oshiro H; Sakuma Y; Sata N; Niki T; Fukushima N Pathol Int; 2019 Feb; 69(2):86-93. PubMed ID: 30729623 [TBL] [Abstract][Full Text] [Related]
18. SOX4 is associated with poor prognosis in cholangiocarcinoma. Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis. Zhou J; Shen W; He X; Qian J; Liu S; Yu G Int J Clin Exp Pathol; 2015; 8(9):9863-74. PubMed ID: 26617696 [TBL] [Abstract][Full Text] [Related]
20. Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma. Huang YC; Chen M; Shyr YM; Su CH; Chen CK; Li AF; Ho DM; Chen YM J Gastroenterol Hepatol; 2008 Sep; 23(9):1384-9. PubMed ID: 18624901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]